. Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. JAMA Neurol. 2021 Jan 1;78(1):102-113. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This is a very nice study. It is the largest GWAS in African Americans so far, though it is far below the sample size of the genetic studies from Europeans, which included almost 100,000 individuals.

    This study suggests that it is possible additional genes can be identified by studying different populations. This will lead to the identification of more genes and networks implicated in AD. If we want to identify all genes involved in Alzheimer’s risk, we need to study different races.

    Overall, I do not think this, or the European-focused studies, identifies race-specific genes and pathways. The variants reported here are specific to African Americans, but I think the identified genes will be implicated in disease independently of race. 

    The results we have so far are just the tip of the iceberg; larger studies will lead to many more hits. Larger studies will also allow more proper comparison of the genetic architecture of AD in African Americans versus non-Hispanic whites.

    My only minor concern with this study is that there is not a real replication study. Therefore, additional studies will be instrumental to confirm that the genes identified here are associated with AD in African Americans.

    View all comments by Carlos Cruchaga

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Largest Alzheimer GWAS in African Americans Finds New Variants

Mutations

  1. APOE R163C